Drug intelligence / Profile preview

Picolight + Clicolon

Development stage
Unknown
Lead developer
National Cancer Center Korea
Modality
Small Molecules
Administration
Oral
01

Overview

Picolight + Clicolon is a combination bowel preparation regimen evaluated for its efficacy and tolerability in patients undergoing colonoscopy for colorectal cancer screening. The regimen combines Picolight, a stimulant and osmotic laxative containing sodium picosulfate, magnesium oxide, and citric acid, with Clicolon, an oral sodium phosphate tablet. Sodium picosulfate is a prodrug metabolized by colonic bacteria into an active metabolite that stimulates colonic peristalsis, while magnesium citrate (formed in solution) and sodium phosphate act as osmotic laxatives, drawing water into the intestinal lumen to facilitate bowel cleansing. This combination approach is designed to reduce the total volume of fluid intake required for preparation, thereby improving patient compliance and reducing side effects compared to standard high-volume polyethylene glycol (PEG) solutions. It has been studied in Phase II trials by the National Cancer Center, Korea.

Brand names
Clicolon
Other names
Picolight plus Clicolon
02

Targets

AKT (RAC-alpha serine/threonine-protein kinase)EGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on Picolight + Clicolon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Picolight + Clicolon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call